Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How to Treat INI1 Negative Non-Rhabdoid Tumours in Adolescents: Following Genotype or Histological Phenotype?

Klinische Padiatrie - 1 Nov 2016

Völker F, Kühnle I, Edler J, Schildhaus H-U, Vokuhl C, Mohr A, Sahlmann C, Kramm C M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Chemoradiotherapy
Share to Ear, External
Share to Maintenance Chemotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nasopharyngeal Neoplasms

Share to Neoplasm Staging

Share to Rhabdoid Tumor

Share to SMARCB1 Protein

Source

Identifiers

PMID: 27246730
DOI: 10.1055/s-0042-103328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How to Treat INI1 Negative Non-Rhabdoid Tumours in Adolescents: Following Genotype or Histological Phenotype?PMID 27246730Read ↗

Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillanceSemantic proximity Read ↗

Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour.Semantic proximity Read ↗

Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).Semantic proximity Read ↗

Update on molecular findings in rhabdomyosarcomaSemantic proximity Read ↗

Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumors.Semantic proximity Read ↗

Pediatric neuroendocrine tumors in Denmark: Incidence, management, and outcome from 1995–2020Semantic proximity Read ↗

Extracranial rhabdoid tumours: what we have learned so far and future directions.Semantic proximity Read ↗

Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.Semantic proximity Read ↗

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypesSemantic proximity Read ↗

[Infant rhabdoid tumors: a diagnostic emergency].Semantic proximity Read ↗

Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging PopulationSemantic proximity Read ↗

GermlineINI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.